Cargando…
COVID-19-Associated Pulmonary Aspergillosis (CAPA)
Invasive Pulmonary Aspergillosis (IPA) has been recognized as a possible secondary infection complicating Coronavirus disease 2019 (COVID-19) and increasing mortality. The aim of this review was to report and summarize the available data in the literature concerning the incidence, pathophysiology, d...
Autores principales: | Dimopoulos, George, Almyroudi, Maria-Panagiota, Myrianthefs, Pavlos, Rello, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346330/ https://www.ncbi.nlm.nih.gov/pubmed/36785564 http://dx.doi.org/10.1016/j.jointm.2021.07.001 |
Ejemplares similares
-
A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
por: Feys, Simon, et al.
Publicado: (2021) -
Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
por: Almyroudi, Maria Panagiota, et al.
Publicado: (2022) -
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020) -
Two cases of COVID‐19‐associated pulmonary aspergillosis (CAPA)
por: Lim, Jin Lee, et al.
Publicado: (2022) -
Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital
por: Paramythiotou, Elisabeth, et al.
Publicado: (2021)